SV Health Investors
Paul LaViolette has a diverse work experience in the healthcare and investment sectors. Paul started their career in 2008 as the Managing Partner & Chief Operating Officer at SV Health Investors, where they are still currently employed. In 2020, they became the Managing Partner at Medtech Convergence Fund. Additionally, they hold various director positions at Vibrato Medical, Inc., Deerfield Catalyst, Edwards Lifesciences, Zerigo Health, CSA Medical Inc., and CardioFocus. Furthermore, they serve as the Chairman of Endotronix and Mass General Brigham Innovation.
Paul LaViolette completed their BA in Psychology at Fairfield University from 1975 to 1979. Subsequently, they pursued an MBA degree from Boston College Carroll School of Management between 1979 and 1981.
SV Health Investors
SV Health Investors, formerly SV Life Sciences, is a leading healthcare and life sciences venture capital and growth equity firm.Their goal is to transform healthcare – one investment at a time – by supporting the entrepreneurs who create and build breakthrough companies and treatments.With over $2 billion in capital under management inseven private healthcare funds, a 20-year track record in the US and Europe and offices in Boston, San Francisco and London, SV Health Investors drives game-changing innovation.